Hi Donna,

In that same paper we also comment on the differences between
expansion/contraction and absolute areal measurements assessed at each face
of the surface (i.e., facewise), which can, after interpolation, be
converted to vertexwise to facilitate analysis using current tools (e.g.,
mri_glmfit or qdec), without loss of areal quantities.

All the best,

Anderson


On 11 October 2014 04:05, Donna Dierker <[email protected]> wrote:

> Hi Emma,
>
> I might not be the only one who is unsure what you mean by a vertex-wise
> cortical surface area measure.  Do you mean something like what is
> illustrated in figures 2 and 3 here:
>
> http://www.pnas.org/content/107/29/13135.figures-only
>
> ... which is similar, but not identical to the local gyrification index?
>
> If so, would you use this measure on surfaces before or after registration
> to a target atlas?
>
> Donna
>
>
> On Oct 10, 2014, at 4:19 PM, Emma Thompson <[email protected]> wrote:
>
> > Dear Freesurfers,
> > I recently heard that there are several disadvantages to using a measure
> of cortical surface area in Freesurfer, specifically due to conducting a
> vertex-wise analysis. Can someone help me understand why a measure of
> surface area using this approach might be flawed? Thanks!
>
>
>
> _______________________________________________
> Freesurfer mailing list
> [email protected]
> https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>
>
> The information in this e-mail is intended only for the person to whom it
> is
> addressed. If you believe this e-mail was sent to you in error and the
> e-mail
> contains patient information, please contact the Partners Compliance
> HelpLine at
> http://www.partners.org/complianceline . If the e-mail was sent to you in
> error
> but does not contain patient information, please contact the sender and
> properly
> dispose of the e-mail.
>
>
_______________________________________________
Freesurfer mailing list
[email protected]
https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer


The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.

Reply via email to